Amyloid β Peptide Other
| Cat. No. | 产品名称/活性 |
|---|---|
| 5053 | AC 186 |
| Decreases Aβ levels in combination with ACP-105; ERβ agonist | |
| 1191 | Amyloid β-Peptide (1-40) (human) |
| Amyloid β-protein fragment | |
| 1428 | Amyloid β-Peptide (1-42) (human) |
| Predominant amyloid β-protein fragment | |
| 0427 | Bromocriptine mesylate |
| Reduces Aβ levels; D2 and D3 receptor agonist | |
| 3945 | Colivelin |
| Neuroprotective peptide; protects against β-amyloid neurotoxicity | |
| 5081 | J 147 |
| Neuroprotective and neurotrophic compound; reduces Aβ40 and Aβ42 levels | |
| 3144 | K 114 |
| Amyloid fibril-specific fluorescent dye | |
| 6517 | Liraglutide |
| Reduces Aβ and soluble amyloid levels in vivo; also highly potent GLP-1 receptor agonist | |
| 4920 | Methoxy-X04 |
| Fluorescent amyloid β detector; brain penetrant | |
| 1098 | Tranilast |
| Antiallergic; binds to Aβ40 monomers | |
| 7659 | Verubecestat |
| Potently reduces Aβ formation in vitro and in vivo; BACE1 and BACE2 inhibitor |
Alzheimer's Life Science Poster
Written by Dimitra Sokolova and Soyon Hong
Our Alzheimer's disease poster summarizes the genetic, molecular and cellular changes observed in the progression of this neurodegenerative disease.
Request copyDownload PDF